Chronic Kidney Disease: Reducing Risks of Progression– Prismic … – The Herald | HeraldOnline.com
|
Chronic Kidney Disease: Reducing Risks of Progression– Prismic …
The Herald | HeraldOnline.com SCOTTSDALE, Ariz., June 13, 2013 — /PRNewswire/ — Prismic Pharmaceuticals, Inc., a Scottsdale, Arizona-based pharmaceutical company, today announced that it has secured exclusive licensing rights to Palmitoylethanolamide (PEA), including the … |
